The Technical Analyst
Select Language :
Theseus Pharmaceuticals, [THRX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Theseus Pharmaceuticals, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Theseus Pharmaceuticals, is listed at the  Exchange

0.12% $4.07

America/New_York / 13 feb 2024 @ 15:59


Theseus Pharmaceuticals,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 181.50 mill
EPS: -1.340
P/E: -3.03
Earnings Date: Mar 08, 2024
SharesOutstanding: 44.65 mill
Avg Daily Volume: 0.850 mill
RATING 2024-02-13
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.03 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.52x
Company: PE -3.03 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 3.99 - 4.13

( +/- 1.65%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-14 Yi Kathy Sell 3 250 Restricted Stock Units
2024-02-14 Yi Kathy Sell 99 634 Stock Option (Right to Buy)
2024-02-14 Stein Steven H Sell 3 250 Restricted Stock Units
2024-02-14 Orbimed Advisors Llc Sell 650 600 Common Stock
2024-02-14 Hayden Donald J Jr Sell 10 000 Common Stock
INSIDER POWER
-10.77
Last 94 transactions
Buy: 24 821 782 | Sell: 19 785 944

Forecast: 01:40 - $4.51

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $4.07 (0.12% )
Volume 0.678 mill
Avg. Vol. 0.850 mill
% of Avg. Vol 79.77 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Theseus Pharmaceuticals, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Theseus Pharmaceuticals, Inc.

RSI

Intraday RSI14 chart for Theseus Pharmaceuticals, Inc.

Last 10 Buy & Sell Signals For THRX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:28sell$4.08N/AActive
Profile picture for
            Theseus Pharmaceuticals, Inc.

THRX

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
WMNTUSDMar 29 - 11:431.160
STSOLUSDMar 29 - 11:44218.73
RAYUSDMar 29 - 11:44$1.922
ORCAUSDMar 29 - 11:433.89
GALXUSDMar 29 - 11:434.95
HAPIUSDMar 29 - 11:4422.87
YF-DAIUSDMar 29 - 11:4148.48
STRKUSDMar 29 - 11:41$14.41
KUJIUSDMar 29 - 11:432.54
UNFIUSDMar 29 - 11:417.52

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.